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A B S T R A C T
Although articular hyaline cartilage typically has low potential for regeneration, numerous methods and techniques
have been proposed to induce the reparation process. In our work, we used microfracture techniques in combination with
intraarticular application of hyaluronic acid in rabbit knee articular cartilage defect. In comparison with the control
group, after 6 and 10 weeks we observed a higher potential of healing in the experimental group, with thicker and more
organized repair tissue filling the defect. In conclusion, a combination of the microfracture technique and application of
hyaluronic acid might be potentially beneficial in inducing articular cartilage defect reparation.
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Introduction
Articular cartilage injuries in the knee have been fre-
quently observed and recognized as a cause of significant
morbidity and disability. It is generally accepted that fo-
cal chondral lesions often progress towards osteoarthri-
tis1.
Curl et al.2 reported 63 % of cartilage lesions in 19,827
knees. Aroen et al.3 described various articular cartilage
abnormalities in 66% of 993 knee arthroscopies.
Chondral defects of the articular surface present a
challenging problem to the orthopedic surgeon because
of the low healing potential of the cartilage4. The goal of
surgery is to alleviate pain, maximize function and pre-
vent further degenerative changes. A number of tech-
niques have been described to treat these lesions5–8.
When considering the options for treating chondral de-
fects, the surgeon must take into account the size, depth,
location and chronicity of the lesion.
In 1994, Rodrigo and Steadman introduced some new
techniques for treating the articular cartilage defect, the
so-called microfracture techniques9. After debriding the
articular defect, the subchondral bone was penetrated
with specially constructed awls to provoke bleeding. The
holes thus formed filled with clots rich in pluripotential
cells and various growth factors which differentiated into
a fibrocartilaginous tissue. Formation of new tissue can
be expected in 6–12 weeks according to Gill et al.10.
Another method used in treating a knee with carti-
lage breakdown, especially a knee with osteoarthritic
change, is the intraarticular application of hyaluronic
acid11–14.
The purpose of this study was to investigate the ther-
apeutic effect of a combined therapeutic method in treat-
ing the full-thickness articular cartilage defect in vivo,
i.e., a combination of microfracture method and hyalu-
ronic acid application.
Materials and Methods
Twenty-four fully grown male New Zealand rabbits,
weighing 4 kg, were used in this study. Following intrave-
nously administrated anesthesia (Ketalar via ear mar-
ginal vein), a medial parapatellar skin incision was made
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and extended through the joint capsule. The patella was
removed laterally and joint surfaces were exposed. A 4 ´
3 mm defect of the articular cartilage (depth 1–2 mm)
was made on the upper quadrant of a medial femoral
condyle using a mini chisel. The base of the articular car-
tilage defect was perforated at 4 consistently distant
points using fine Kirshner wire and creating microfrac-
tures of the subchondral bone (Figure 1). This resulted
in bleeding of the subchondral blood vessels. After this
treatment, the wound was sutured in two layers with
absorbable sutures and the animals were given an antibi-
otic. After the surgery, the animals were not immobilized
and were allowed free movement and activity in their
cages of standard dimensions. The animals were divided
into two groups according to the postoperative treatment
as follows:
1. The experimental group of animals that received an
intraarticular injection of hyaluronic acid (0.5 mL so-
dium-hyaluronat, commercial product Hyalgan, 2 mL,
concentration of 1% hyaluronic acid, Fidia S.p.A., Abano
Terme, Italy) once weekly for 5 weeks.
2. The control group of animals received an intra-
articular injection 0.5 mL bufferet saline without the ac-
tive substance – hyaluronic acid, once weekly for 5 weeks.
The animals were euthanized with an overdose of
pentobarbiton until cardiac arrest was achieved. The tis-
sues were then harvested for microscopic analysis.
From each animal group, 6 animals were sacrificed at
each time point (6 and 10 weeks after surgery).
Tissue processing and histology
The knee joint of each sacrificed animal was opened
and the femur dislocated from the tibia. The distal part
of the femur was excised and rinsed with saline, fixed in
4% paraformaldehyde, dehydrated in ethanol, cleared in
xylene and embedded undecalcified in methyl metacry-
late. Serial slices of the tissue samples were cut to a
thickness of 7 mm using a microtome (Leica RM 2155)
equipped with a tungsten carbide knife. They were then
mounted on silinated glass slides (Silane-Prep slides,
Sigma S 4651), dried at 37 °C and stained with toluidin
blue.
The articular cartilage obtained from both groups of
animals was graded using the International Cartilage
Repair Society (ICRS) Visual Histological Assessment
Scale by one blinded observer15 (Table 1).
The analysis of the presence of specific features sco-
red by ICRS scale was performed using Pearson, c2 test
or Fischers’ excat test. All statistical values were consid-
ered significant at the P level of <0.05.
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Fig. 1. Articular defect formed by chisel was drilled with
K-wire till the subchondral bone.
TABLE 1
THE ICRS VISUAL HISTOLOGICAL ASSESSMENT SCALE
Histological criteria Score
Articular surface
smooth/continuous
irregularities/discontinuous
3
0
Matrix
hyaline
mixture (hyaline / fibrocartilage)
fibrocartilage
fibrous tissue
3
2
1
0
Cell distribution
columnar
mixed (columnar / clusters)
clusters
individual cells / disorganized
3
2
1
0
Cell population viability
predominantly viable
partially viable
< 10% viable
3
1
0
Subchondral bone
normal
increased remodeling
bone necrosis / granulation tissue
detached / fracture / callus at base
3
2
1
0
Cartilage mineralization
normal
abnormal / inappropriate location
3
0
All the surgical procedures performed on the experi-
mental animals were approved by the ethics committee
of the University of Rijeka School of Medicine.
Results
Histological sample analysis of the control group at
6th and 10th week revealed that articular cartilage defects
were filled with repair tissue which varied widely from a
disorganized fibrous tissue with incorporated bone frag-
ments undergoing reabsorption to fibrous cartilage or is-
lands of hyaline cartilage. The edges of the original artic-
ular cartilage could be recognized as a sharp demarcation
line. The bottom of the defect showed changes in the
bone architecture with regard to the adjacent subchon-
dral bone, the bone trabeculas being smaller but more
numerous and showing necroses and detachment. The
appearance of the healing process was not uniform in all
tissue samples and no common morphological pattern
could be recognized.
In the experimental group, the histological samples
showed that the articular cartilage defects were filled
with fibrous cartilage with numerous chondrocyte clus-
ters (Figure 2). Reparative tissue reached the level of
normal cartilage. The edges of the defects showed the
sites of bone reabsorption but the adjacent articular car-
tilage seemed unchanged and continuously bonded to the
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TABLE 2
RESULTS IN BOTH GROUPS ACCORDING TO THE ICRS FEATURES WITH STATISTICAL ANALYSIS
ICRS score
After 6 weeks After 10 weeks
Control
Group
Experimental
group
Statistics
Control
Group
Experimental
group
Statistics
Art. Surface Number Number P Number Number P
0 12 4 0.001* 6 3 0.581
3 0 8 7 9
Matrix
0 8 4 0.085 4 0 <0.001*
1 4 8 6 0
2 0 0 2 12
3 0 0 0 0
Cell distr.
0 12 3 <0.001* 8 0 0.039*
1 0 9 3 10
2 0 0 1 2
3 0 0 0 0
Cell pop. Viabil.
0 2 3 0.162 7 0 0.005*
1 10 7 5 11
3 0 2 0 1
Subcho. Bone
0 4 1 0.256 3 0 <0.001*
1 8 11 9 0
2 0 0 0 12
3 0 0 0 0
Cartil mineral.
0 6 8 0.581 9 8 0.276
3 6 4 3 6
* statisticaly, Pearson, c2 test or Fischers’ excat test
Fig. 2. Chondrocytic clusters
(toluidin blue, magnification 400 X).
repair tissue that filled the defect. The bottom of the de-
fect showed no clear demarcation line between the repair
tissue and the underlying subchondral bone. The sub-
chondral bones showed signs of increased remodeling
(Figure 3a-b). Table 2 shows the number of joints for
each histological feature for the control and the experi-
mental groups scored by ICRS visual histological assess-
ment with statistical analysis.
Analyzing Table 2, it is interesting to note that after
the 6th week all joints in the control group had an irregu-
lar and discontinuous articular surface, while in the ex-
perimental group 8 joints had score 3, which means that
surface of the articular cartilage was in continuity. Simi-
lar results were observed analyzing the cell distribution.
The result was statistically significant. After the 6th
week, there was no significant difference in any other
feature of the ICRS scale between the two groups. Ana-
lyzing the joints after the 10th week, the difference was
statistically significant in four of six features of the ICRS
scale. It is important to observe that at this moment
there was no difference between the control and the ex-
perimental group as regards the articular surface. The
other feature which did not show any significant differ-
ence was cartilage mineralization.
Discussion and Conclusion
When an articular cartilage defect is treated with
microfracture techniques as described by Steadman16,17
repair tissue is formed. Mechanical and biological micro-
environmental factors in the joint contribute towards di-
fferentiating mesenchimal cell into cartilage tissue18–21.
The repair tissue formed by microfracture techniques
consists predominantly of collagen type I, which resem-
bles fibrocartilage and does not resist shear and compres-
sion loads as does normal hyaline cartilage. The method
proved to be effective, showing a significant improve-
ment in ability and symptom regression.
Another method used in treating the knee with carti-
lage breakdown, as in osteoarthritis, is the application of
the hyaluronic acid22. Hyaluronic acid is a critical compo-
nent of normal synovial fluid and an important contribu-
tor to joint homeostasis23. The clinical benefits of intra-
-articular hyaluronic acid injections are supposed to occur
through improved joint lubrication. While the physical
properties of hyaluronic acid are important, there is evi-
dence to suggest that hyaluronic acid may provide physi-
ological, pharmachological and anabolic activity24–26. Mo-
reover it may have a great influence on chondrocyte
activity and the ability to synthesize essential compo-
nents of the articular cartilage extracellular matrix27.
Analyzing the literature, we could find that only Kang
et al. combined the microfracture techniques in with
hyaluronan28. The other parts of the protocol, which in
our opinion can significantly influence the final results,
were completely different. While Kang et al. used one-
-time application of hyaluronic acid stabilized with gel,
our method of application was identical to the one used
for patients in hospital and consisted of 5 intraarticular
injections given once a week. It is well known that molec-
ular mass can influence the result. We used the low mo-
lecular hyaluronan with of 500–730 kD, while others
used the high molecular weight of 3000 kD. For evaluat-
ing the results we used the ICRS scale which can numeri-
cally describe the possible difference between the experi-
mental and the control group.
Our study confirmed some benefits other than the
physical properties of the hyaluronic acid itself. When, in
our experimental group, pluripotent cells from a blood
clot were exposed to hyaluronic acid, some biological ac-
tivity was also observed.
Six weeks after the surgery only a minor difference
between the two groups was observed: the experimental
group had a smoother surface and the cells were more or-
ganized.
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Fig. 3.a) Microphotograph of the histological section of articular cartilage defect reparative tissue in animal from the control group
treated with microfracture only and b) animals from the experimental group treated with microfracture and hyaluronic acid, 10 weeks
after injury (toluidin blue, magnification 100 X). The arrows indicate edges of the defect.
Ten weeks after the surgery, a significant improve-
ment in almost all other features of the ICRS scale was
observed in the experimental group (Table 2). This im-
provement consisted in the following: the reparative tis-
sue reached the level of normal cartilage, while the tissue
in the control group filled only the bottom of the defect;
the reparative tissue was more organized and had a
higher cellularity; the cells were organized in numerous
clusters, indicating a better mitotic activity in the area of
regeneration; and the subchondral bone in the experi-
mental group showed increasing remodeling and tight
continuity with the repair tissue that fills the articular
defect.
Hyaluronic acid is known to have a biological effect on
chondrocytes and synoviocytes, but it appears to have
the same effect on mesenchymal cells as well, as was
shown in our experiment.
In conclusion, we can say that the combination of the
two techniques used showed a significant improvement
in healing cartilage defects.
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LIJE^ENJE O[TE]ENJA HRSKAVICE KOLJENOG ZGLOBA TEHNIKOM MIKROFRAKTURA
UZ INTRAARTIKULARNU PRIMJENU HIJALURONANA (NATRIJEVE SOLI HIJALURONSKE
KISELINE) U KUNI]A
S A @ E T A K
Hrskavi~no tkivo ima slab potencijal cijeljenja. Predlo`ene su brojne tehnike s ciljem ubrzanja pobolj{anja kvalitete
cijeljenja. U na{em radu na ze~ijem modelu kori{tena je kombinacija kirur{ke tehnike mikrofraktura uz dodatak intra-
artikularne aplikacije soli hijaluronske kiseline. Nakon 6 odnosno 10 tjedana od kirur{kog zahvata uo~en je ve}i poten-
cijal cijeljenja u eksperimentalnoj grupi uz stvaranje obilnijeg, celularnijeg i bolje organiziranog reparacijskog tkiva u
hrskavi~nom defektu. Zaklju~no mo`emo re}i da kombinacija navedenih tehnika zna~ajno unaprije|uje cijeljenje loka-
liziranih defekata zglobne hrskavice u koljenu zeca.
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